Mendelian randomisation analysis for intestinal disease: achievement and future

Xixian Ruan1, Tianyi Che2, Xuejie Chen1

  • 1Department of Gastroenterology, Central South University Third Xiangya Hospital, Changsha, Hunan, China.

Egastroenterology
|February 13, 2025
PubMed
Summary

Mendelian randomization (MR) strengthens causal inference for intestinal disease risk factors, validating lifestyle and obesity links. Future research should focus on multiomics and diverse ancestries for broader insights.